----- Original Message ----- From: <m.seher-zupancic@xxxxxxxxxxxxx>
To: <nevenka.lepin@xxxxxxx> Sent: Sunday, January 27, 2013 5:02 PM Subject: Posredovano: Confirmed Speakers at The ESCMID Conference Prosim, da posredujete obvestilo članom po e-pošti. Lep pozdrav, Margareta
From: "2nd ESCMID Conference on the Impact of Vaccines on Public Health" <2nd_ESCMID_Conference_on_the_Imp@xxxxxxxxxxxxxx>To: m.seher-zupancic@xxxxxxxxxxxxx Subject: Confirmed Speakers at The ESCMID Conference Date: Wed, 09 Jan 2013 13:05:11 +0000 -http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/51aefb7b75/ref3=db1 This message is also available online - click here-http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/88edf745b1 - http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/8e04426908 -http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/d30217c22b Still time to save, secure your place today! 2nd ESCMID Conference on the Impact of Vaccines on Public Health Confirmed speakers The conference will bring together specialists and physicians in training in infectious diseases, clinical microbiology, hygiene, public health, vaccinology and other disciplines dealing with all aspects of vaccination. The rich and broad set of topics that will be debated and discussed by world experts include: Zsuzsanna Jakab The role of WHO-Europe Piotr Kramarz The role of ECDC Sergio Abrignani Hepatitis C vaccines: myth or reality? Stefano Aliberti Role of vaccines in preventing pneumococcal diseases Fabienne Anjuere Novel subject delivery vaccine technologies Patricia Blank Influenza immunisation in elderly Paolo Bonanni Lifelong vaccination as a key disease-prevention strategy Robb Butler Contrasting the anti-vaccine movements Paloma Carrillo Chickenpox vaccination: a laboured take off Joe Cohen The status of malaria vaccine research and development: results from the phase 3 trial of the RTS,S candidate Ron Dagan Vaccines to constrain antimicrobial resistance Katrin Dubischar-Kastner Japanese Encephalitis vaccines Giovanni Delogu New vaccines against tuberculosis Susanna Esposito Multivalent paediatric vaccines Bernard Fritzell Pneumococcal vaccination in the EU: current status and perspectives Paul Heath The potential role of GBS vaccination: overall value and the hurdles of prenatal programmes Franz X. Heinz Tick-borne encephalitis and its prevention by vaccination Suresh Jadhav Emerging economies from consumers to new donor countries Kari Johansen The possible evolution of paediatric influenza vaccination in Europe Elmar Joura Next-generation HPV vaccines: challenges and perspective Karen Kotloff New and candidate vaccines for gastrointestinal infections Pavla Krizova Pneumococcal vaccination: do we need a new implementation strategy? Pierluigi Lopalco Actual immunisation coverage throughout Europe: are existing data sufficient? Mark Muscat Eliminating rubella and preventing congenital rubella syndrome in Europe Ragnar Norrby Tetravalent Dengue vaccine – from research to phase III Albert Osterhaus Flu vaccination facing flu virus mutability Dina Pfeifer Measles elimination and the interruption of indigenous transmission Mariagrazia Pizza Innovative strategies for meningococcal vaccines Maarten J. Postma Pertussis boostering in adults Richard A. Proctor A vaccine for Staphylococcus aureus? Rino Rappuoli From genomics to structural vaccinology Gernot Rohde Pneumococcal infection in adults: burden of disease Connie S. Schmaljohn Recombinant DNA-derived vaccines for VHF Margaret Stanley Implementing HPV vaccination: where do we stand now? Christoph Steininger CMV vaccine: phase II trial results Pierre Van Damme Hepatitis B vaccination in Western European countries Timo Vesikari Norovirus vaccine: first results Ning-Shao Xia Hepatitis E vaccines: phase II and phase III trials Access the full scientific programme details here - http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/7e59ed1046 Register now - http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/60957e6601 The -http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/245f6743cb 2nd ESCMID Conference on the Impact of Vaccines on Public Health isyour opportunity to participate in an important gathering that will bring together world-leading experts to debate the various correlations between vaccines and infectious diseases in the 21st century. *Fees include scientific sessions, printed conference material, lunches and coffee breaks. Download the registration form here - http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/231f7a8c16 Discover the beautiful city of Prague -http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/20f3422365 -http://cts.vresp.com/c/?KenesInternationalUK/97598b815c/c8569c34da/caa5ee5ba8 The 2nd ESCMID Conference is being held in Prague, Czech Republic. Prague is the city of bridges and boasts more than ten major museums, along with numerous theatres, galleries, cinemas, and other historical exhibits. A modern public transportation system connects the city. Renowned for its central role in the history of Europe, Prague claims scores of important individuals who have paid their tribute to this majestic city. Its beauty and imposing architecture have enchanted the likes of Mozart, Beethoven, Apollinaire, Tchaikovsky, Dostojevski and Rodin and Kokoschka as well as Queen Elizabeth II, Pope John Paul II and many others. Prague’s uniqueness gives the city a grand and mysterious atmosphere that is simultaneously intimate and inviting. What a great city to stage a conference! The Conference is supported by: Scientific Secretariat Giuseppe Cornaglia Dept. of Pathology and Diagnostics University of Verona Phone +39 045 802 71 96 Fax +39 045 802 71 01 E-mail: - giuseppe.cornaglia@xxxxxxxx giuseppe.cornaglia@xxxxxxxx Conference Secretariat ICO Marco Moschin Via Lorenzo Marcello 32 30126 Lido di Venezia Italy Phone +39 041 52 62 530 Fax +39 041 52 71 129 - ico@xxxxxxxxxxxxxxxxx%20 E-mail: ico@xxxxxxxxxxxxxxxxx ______________________________________________________________________ Click to view this email in a browser http://hosted.verticalresponse.com/603563/97598b815c/1573305853/c8569c34da/ If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: http://cts.vresp.com/u?97598b815c/c8569c34da/mlpftw ______________________________________________________________________ This message was sent by 2nd ESCMID Conference on the Impact of Vaccines on Public Health using VerticalResponse Kenes International- UK 1st Floor, Chesterfield House 385 Euston Road London, England NW1 3AU UK Read the VerticalResponse marketing policy: http://www.verticalresponse.com/content/pm_policy.html